These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30710503)

  • 1. The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout.
    Szekanecz Z; Szamosi S; Kovács GE; Kocsis E; Benkő S
    Arch Biochem Biophys; 2019 Jul; 670():82-93. PubMed ID: 30710503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout.
    Ahn H; Lee G; Lee GS
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPS8 regulates an NLRP3 inflammasome-independent caspase-1 activation pathway in monosodium urate crystal-treated RAW264.7 macrophages.
    Chuang JP; Kao CY; Lee JC; Ling P; Maa MC; Leu TH
    Biochem Biophys Res Commun; 2020 Sep; 530(3):487-493. PubMed ID: 32595041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication.
    Jhang JJ; Lin JH; Yen GC
    J Agric Food Chem; 2018 Jan; 66(4):765-772. PubMed ID: 29293001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
    Lee HE; Yang G; Kim ND; Jeong S; Jung Y; Choi JY; Park HH; Lee JY
    Sci Rep; 2016 Dec; 6():38622. PubMed ID: 27934918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
    Yang G; Yeon SH; Lee HE; Kang HC; Cho YY; Lee HS; Lee JY
    Rheumatology (Oxford); 2018 Apr; 57(4):727-736. PubMed ID: 29340626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
    Zhou M; Li S; Song L; Hu Q; Liu W
    Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
    Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
    Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.
    Goldberg EL; Asher JL; Molony RD; Shaw AC; Zeiss CJ; Wang C; Morozova-Roche LA; Herzog RI; Iwasaki A; Dixit VD
    Cell Rep; 2017 Feb; 18(9):2077-2087. PubMed ID: 28249154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaetocin attenuates gout in mice through inhibiting HIF-1α and NLRP3 inflammasome-dependent IL-1β secretion in macrophages.
    Mian Wu ; Zhang M; Ma Y; Liu F; Chen S; Lu J; Chen H
    Arch Biochem Biophys; 2019 Jul; 670():94-103. PubMed ID: 31255694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage.
    Choi N; Yang G; Jang JH; Kang HC; Cho YY; Lee HS; Lee JY
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
    Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
    Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.
    Qiao CY; Li Y; Shang Y; Jiang M; Liu J; Zhan ZY; Ye H; Lin YC; Jiao JY; Sun RH; Zhang ZH; Piao MH; Wu YL; Nan JX; Lian LH
    Inflammopharmacology; 2020 Dec; 28(6):1481-1493. PubMed ID: 33006110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of IL-1β From Monocytes in Gout Is Redox Independent.
    Alberts BM; Bruce C; Basnayake K; Ghezzi P; Davies KA; Mullen LM
    Front Immunol; 2019; 10():70. PubMed ID: 30761138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis.
    Lee HE; Yang G; Park YB; Kang HC; Cho YY; Lee HS; Lee JY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31174271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precipitation of Soluble Uric Acid Is Necessary for
    Alberts BM; Barber JS; Sacre SM; Davies KA; Ghezzi P; Mullen LM
    J Rheumatol; 2019 Sep; 46(9):1141-1150. PubMed ID: 30824640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of mitochondrial pyruvate carrier promotes NLRP3 inflammasome activation and gout development via metabolic reprogramming.
    Chen LC; Chen YJ; Lin HA; Chien WC; Tsai KJ; Chung CH; Wang JY; Chen CC; Liao NS; Shih CT; Lin YY; Huang CN; Ojcius DM; Huang KY; Lin HC
    Immunology; 2023 Jul; 169(3):271-291. PubMed ID: 36708143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice.
    Xue Y; Li R; Fang P; Ye ZQ; Zhao Y; Zhou Y; Zhang KQ; Li L
    J Mol Endocrinol; 2021 Jun; 67(2):27-40. PubMed ID: 34047713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail.
    Wu H; Wang Y; Huang J; Li Y; Lin Z; Zhang B
    Biomed Pharmacother; 2023 Feb; 158():114175. PubMed ID: 36587556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors.
    Tian Y; He X; Li R; Wu Y; Ren Q; Hou Y
    Bioorg Med Chem; 2024 Oct; 112():117874. PubMed ID: 39167977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.